-transparent.png){kind=logo}
A series of carboxymethylpullulan (CMPul)-doxorubicin (DXR) conjugates bound by peptide spacers of different compositions and lengths were prepared and evaluated for their in vivo antitumor effects. Systematic study of the peptide spacers indicated that CMPul-DXR conjugates bound via appropriate dipeptide spacers were more potent than DXR.
Related Publications
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
December 2000,
Japanese journal of cancer research : Gann,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
January 2022,
Pharmaceuticals (Basel, Switzerland),
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
January 1989,
Chemico-biological interactions,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
January 2009,
Bioconjugate chemistry,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
January 2015,
Current topics in medicinal chemistry,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
February 2001,
Anti-cancer drugs,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
October 2014,
Metallomics : integrated biometal science,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
July 2022,
Bioconjugate chemistry,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
December 2002,
Bioorganic & medicinal chemistry letters,
H Nogusa, and
T Yano, and
N Kashima, and
K Yamamoto, and
S Okuno, and
H Hamana
August 1989,
Arzneimittel-Forschung,
